Jamjoom Pharmaceuticals Factory Co. announces the Signing of a Non-Binding Term Sheet with Pharmaceutical Investment Company, in relation to a potential strategic partnership
| Element List | Explanation |
|---|---|
| Introduction | Jamjoom Pharmaceuticals Factory Co (the “Company”) announces the signing of a non-binding term sheet on 05/05/1447H (corresponding to 27/10/2025G) with Pharmaceutical Investment Company (Lifera), a Public Investment Fund (PIF) company focused on the localization and expansion of Saudi Arabia’s biopharmaceutical sector, in relation to establishing a joint venture to develop, manufacture, and commercialize vaccines, biologics, and biosimilars within the Kingdom of Saudi Arabia (the “Joint Venture”) |
| Memorandum Signing Date | 2025-10-27 Corresponding to 1447-05-05 |
| Counterparty | Pharmaceutical Investment Company (closed joint stock company), a Public Investment Fund (PIF) company |
| Memorandum Subject | The term sheet represents a preliminary non-binding agreement regarding the Joint Venture and its key provisions. The term sheets included the parties’ agreement to negotiate in good faith to reach a final binding agreement as well as other customary provisions like confidentiality and other clauses. |
| Memorandum Duration | The term sheet will terminate at the time the definitive agreements are executed, or in case of termination by either party by way of a 30-day notice to the other. |
| Related Parties | There are no related parties. |
| Financial Impact | There is currently no financial impact as the term sheet is not binding. |
| Additional Information | The term sheet is non-binding, and the agreement on the Joint Venture is subject to the parties reaching a final binding agreement and to any required approvals. There is no assurance that the final agreements will be signed or that the Joint Venture will materialize.
The Company will announce any material developments in due course including the entry into the definitive agreements with Pharmaceutical Investment Company and the details thereof. |
| Attached Documents |  |
Comments